According to Lifevantage's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.478463. At the end of 2023 the company had a P/S ratio of 0.3616.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.3616 | 59.73% |
2022 | 0.2264 | -40.94% |
2021 | 0.3833 | -33.36% |
2020 | 0.5752 | -40.79% |
2019 | 0.9715 | 12.74% |
2018 | 0.8618 | 147.08% |
2017 | 0.3488 | -35.11% |
2016 | 0.5375 | -24.22% |
2015 | 0.7093 | 16.47% |
2014 | 0.6090 | -27.27% |
2013 | 0.8373 | -37.1% |
2012 | 1.33 | -34.01% |
2011 | 2.02 | 51.48% |
2010 | 1.33 | -38.29% |
2009 | 2.16 | 50.25% |
2008 | 1.44 | 10.48% |
2007 | 1.30 | -23.83% |
2006 | 1.71 | -72.18% |
2005 | 6.14 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Oragenics OGEN | N/A | N/A | ๐บ๐ธ USA |
Nature's Sunshine Products NATR | 0.6343 | 32.56% | ๐บ๐ธ USA |
USANA USNA | 0.9887 | 106.63% | ๐บ๐ธ USA |